Gastroesophageal reflux disease in COPD: Links and risks

International Journal of COPD

Volumn 10, Issue 1, 2015, Pages 1935-1949

  Lee, Annemarie L ^a,b   Goldstein, Roger S ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b AUSTIN HOSPITAL   (Australia)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

COPD; GERD; Pulmonary aspiration; Treatment

Indexed keywords

ANTACID AGENT; ANTIBIOTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; HISTAMINE H2 RECEPTOR ANTAGONIST; PEPSIN A; PROTON PUMP INHIBITOR; THEOPHYLLINE;

ASTHMA; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPHAGIA; ESOPHAGEAL PH MONITORING; ESOPHAGUS MOTILITY; FORCED EXPIRATORY VOLUME; GASTROESOPHAGEAL REFLUX; HEARTBURN; HOSPITALIZATION COST; HUMAN; HYPERINFLATION; LIFESTYLE MODIFICATION; LOWER ESOPHAGUS SPHINCTER PRESSURE; PATHOPHYSIOLOGY; PREVALENCE; PULMONARY ASPIRATION; QUALITY OF LIFE; REVIEW; SEX DIFFERENCE; SMOKING; STOMACH FUNDOPLICATION; SYMPTOM ASSESSMENT; COMPLICATION; DISEASE COURSE; RISK FACTOR;

COMORBIDITY; DISEASE PROGRESSION; GASTROESOPHAGEAL REFLUX; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RISK FACTORS;

EID: 84941890661     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S77562     Document Type: Review

References (123)

1. Global Initiative for Chronic Obstructive Pulmonary Disease [homepage on the Internet]. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease; 2014. Available from: http://www.goldcopd. Accessed 24 February, 2015.
2. Seemungal T, Donaldson G, Paul E, Bestall J, Jeffries D, Wedzicha J. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157: 1418-1422.
3. Vos T, Flaxman A, Naghavi M. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2163-2196.
4. Seemungal T, Donaldson G, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161: 1608-1613.
5. Rycroft C, Heyes A, Lanza L, Becker K. Epidemiology of chronic obstructive pulmonary disease: a literature review. Int J Chron Obstruct Pulmon Dis. 2012;7:457-494.
6. Vakil N, Van Zanten S, Kahrilas PJ, Dent J, Jones R. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101: 1900-1920.
7. El-Serag H, Sweet S, Winchester C, Dent J. Update on the epidemiology of gastro-oesophageal disease: a systematic review. Gut. 2014; 63(6):871-880.
8. SifrimD, Holloway R, Silny J. Acid, nonacid, and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hour pH-impedance recordings. Gastroenterology. 2001;120(7):1588-1598.
9. Ducoloné A, Vandevenne A, Jouin H, et al. Gastroesophageal reflux in patients with asthma and chronic bronchitis. Am Rev Respir Dis. 1987;135:327-332.
10. Sweet M, Patti M, Hoopes C, Hayes SR, Golden JA. Gastro-oesophageal reflux and aspiration in patients with advanced lung disease. Thorax. 2009;64:167-173.
11. Casanova C, Baudet JS, del Valle Velasco M, et al. Increased gastrooesophageal reflux disease in patients with severe COPD. Eur Respir J. 2004;23:841-845.
12. Mokhlesi B, Morris A, Huang C-F, Curcio A, Barrett T, Kamp D. Increased prevalence of gastroesophageal reflux symptoms in patients with COPD. Chest. 2001;119(4):1043-1048.
13. Mittal R, Holloway R, Penagini R, Blackshaw L, Dent J. Transient lower esophageal sphincter relaxation. Gastroenterology. 1995;109:601-610.
14. Schoeman MN, Tippett MD, Akkermans LM, Dent J, Holloway RH. Mechanisms of gastroesophageal reflux in ambulant healthy human subjects. Gastroenterology. 1995;108(1):83-91.
15. Mittal R, McCallum R. Characteristics and frequency of transient relaxations of the lower esophageal sphincter in patients with reflux esophagitis. Gastroenterology. 1988;95:593-599.
16. Dent J, Holloway R, Toouli J, Dodds W. Mechanisms of lower oesophageal sphincter incompetence in patients with symptomatic gastro-oesophageal reflux. Gut. 1988;29:1020-1028.
17. Chandrasoma P, DeMeester TR. GERD: Reflux to Esophageal Adenocarcinoma. San Diego: Elsevier; 2006.
18. Vandenplas Y, Hassall E. Mechanisms of gastroesophageal reflux and gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr. 2002;35(2):119-136.
19. Richter J. Gastroesophageal reflux disease. In: Yamada T, editor. Textbook of Gastroenterology. Philadelphia: Lippincott Williams and Williams; 2003:1196-1224.
20. Kahrilas P, Dodds WJ, Hogan W. Effect of peristaltic dysfunction on esophageal volume clearance. Gastroenterology. 1988;94:73-80.
21. Katz PO, Gerson LB, Vela MF. Corrigendum: guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108:308-328.
22. Klauser A, Schindlbeck N, Muller-Lissner S. Symptoms in gastrooesophageal reflux disease. Lancet. 1990;335:205-208.
23. Locke GI, Talley N, Fett S. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology. 1997;112:1448-1456.
24. Flook N, Jones R, Vakil N. Approach to gastroesophageal reflux disease in primary care. Putting the Montreal definition into practice. Can Fam Physician. 2008:54:701-705.
25. Stanghellini V, Armstrong D, Monnikes H, Bardhans K. Systematic review: do we need a new gastro-oesophageal reflux disease questionnaire? Aliment Pharmacol Ther. 2004;19:463-489.
26. Fraser A, Delaney B, Moayyedi P. Symptom-based outcome measures for dyspepsia and GERD trials: a systematic review. Am J Gastroenterol. 2005;100:442-452.
27. Juul-Hansen P, Rydning A, Jackobsen C, Hansen T. High dose proton-pump inhibitors as a diagnostic test of gastro-oesophageal reflux disease in endoscopic-negative patients. Scand J Gastroenterol. 2001;36:806-810.
28. Fass R, Ofman J. Gastroesophageal reflux disease - should we adopt a new conceptual framework? Am J Gastroenterol. 2002;97(8): 1901-1909.
29. Richter J. Severe reflux esophagitis. Gastroenterol Clin North Am. 1994;4:677.
30. DeMeester TR, Wang CI, Wernly JA, et al. Techniques, indications and clinical use of 24 hour oesophageal monitoring. J Thorac Cardiovasc Surg. 1980;79:656-670.
31. Jamieson JR, Stein HJ, DeMeester TR, et al. Ambulatory 24-pH esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity and reproducibility. Am J Gastroenterol. 1992;87(9): 1102-1111.
32. Streets C, DeMeester T. Ambulatory 24-hour esophageal pH monitoring: why, when and what to do. J Clin Gastroenterol. 2003; 37(1):14-22.
33. Johnsson F, Joelsson B, Isberg P-E. Ambulatory 24 hour intraesophageal pH-monitoring in the diagnosis of gastroesophageal reflux disease. Gut. 1987;28:1145-1150.
34. Dobhan R, Castell D. Normal and abnormal proximal esophageal acid exposure: results of ambulatory dual-probe pH monitoring. Am J Gastroenterol. 1993;88(1):25-29.
35. Johnson L, DeMeester T. Twenty-four pH monitoring of the distal esophagus: a quantitative measure of gastroesophageal reflux. Am J Gastroenterol. 1974;62:325-332.
36. Vaezi M, Schroeder P, Richter J. Reproducibility of proximal probe pH parameters in 24-hour ambulatory pH monitoring. Am J Gastroenterol. 1997;92:825-829.
37. Emerenziani S, Ribolsi M, Pasqualetti P, Cicala M. Proximal reflux sensitivity: measurement of acid exposure of proximal esophagus: a better tool for diagnosing non-erosive reflux disease. Neurogastroenterol Motil. 2011;23(711):e324.
38. Katz PO, Matheus T. Telemetry capsule for ambulatory pH monitoring: is it time for a change? Am J Gastroenterol. 2008;103: 2986-2987.
39. Shay S, Bomeli S, Richter J. Multichannel intraluminal impedance accurately detects fasting, recumbent reflux events and their clearing. Am J Physiol Gastrointest Liver Physiol. 2002;283:376-383.
40. Sifrim D, Silny J, Holloway R, Janssens J. Patterns of gas and liquid reflux during transient lower esophageal sphincter relaxation. A study using intraluminal electrical impedance. Gut. 1999;44:47-54.
41. D’Ovidio F, Singer LG, Hadjiliadis D, et al. Prevalence of gastroesophageal reflux in end-stage lung disease candidates for lung transplant. Ann Thorac Surg. 2005;80:1254-1261.
42. Sweet MP, Herbella FA, Leard L, et al. The prevalence of distal and proximal gastroesophageal reflux in patients awaiting lung transplantation. Ann Surg. 2006;244(4):491-497.
43. Sole ML, Conrad J, Bennett M, et al. Pepsin and amylase in oral and tracheal secretions. A pilot study. Am J Crit Care. 2014;23(4): 334-338.
44. Potluri S, Friedenberg F, Parkman HP, et al. Comparison of a salivary/ sputum pepsin assay with 24-hour esophageal pH monitoring for detection of gastric reflux into the proximal esophagus, oropharynx and lung. Dig Dis Sci. 2003;48(9):1813-1817.
45. Ward C, Forrest IA, Brownlee IA, et al. Pepsin like activity in bronchoalveolar lavage fluid is suggestive of gastric aspiration in lung allografts. Thorax. 2005;60:872-874.
46. Stovold R, Forrest IA, Corris PA, et al. Pepsin, a biomarker of gastric aspiration in lung allografts. A putative association with rejection. Am J Respir Crit Care Med. 2007;175:1298-1303.
47. Blondeau K, Mertens V, Vanaudenaerde BA, et al. Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection. Eur Respir J. 2008;31:707-713.
48. Reder N, Davis C, Kovacs E, Fisichella P. The diagnostic value of gastroesophageal reflux disease (GERD) symptoms and detection of pepsin and bile acids in bronchoalveolar lavage fluid and exhaled breath condensate for identifying lung transplantation patients with GERDinduced aspiration. Surg Endosc. 2014;28(6):1794-1800.
49. Lee AL, Button B, Denehy L, et al. Proximal and distal gastro-oesophageal reflux in chronic obstructive pulmonary disease and bronchiectasis. Respirology. 2014;19(2):211-217.
50. Timms C, Thomas P, Yates D. Detection of gastro-oesophageal reflux disease (GORD) in patients with obstructive lung disease using exhaled breath profiling. J Breath Res. 2012;6:016003.
51. Kostikas K, Papatheodorou G, Ganas K, Psathakis K, Panagou P, Loukides S. pH in expired breath condensate of patients with inflammatory airway diseases. Am J Respir Crit Care Med. 2002;165(10):1364-1370.
52. Terada K, Muro S, Sato S, et al. Impact of gastro-oesophageal reflux disease symptoms on chronic obstructive pulmonary disease exacerbation. Thorax. 2008;63:951-955.
53. Martinez CH, Okajima Y, Murray S, et al; COPDGene Investigators. Impact of self-reported gastroesophageal reflux disease in subjects from COPD Gene cohort. Respir Res. 2014;15:62.
54. Liang B-M, Feng Y-L. Association of gastroesophageal reflux disease symptoms with stable chronic obstructive pulmonary disease. Lung. 2012;190:277-282.
55. Rogha M, Behravesh B, Pourmoghaddas Z. Association of gastroesophageal reflux disease symptoms with exacerbations of chronic obstructive pulmonary disease. J Gastrointest Liver Dis. 2010;19(3):253-256.
56. Kempainen R, Savik K, Whelan T, Dunitz J, Herrington C, Billings J. High prevalence of proximal and distal gastroesophageal reflux disease in advanced COPD. Chest. 2007;131:1666-1671.
57. Rascon-Aguilar IE, Pamer M, Wludyka P, et al. Role of gastroesophageal reflux symptoms in exacerbations of COPD. Chest. 2006; 130:1096-1101.
58. Bor S, Kitapcioglu G, Solak Z, Ertilav M, Erdinc M. Prevalence of gastroesophageal reflux disease in patients with asthma and chronic obstructive pulmonary disease. J Gastroenterol Hepatol. 2010;25:309-313.
59. Shimizu Y, Dobashi K, Kusano M, Mori M. Different gastroesophageal reflux symptoms of middle-aged to elderly asthma and chronic objective pulmonary disease patients. J Clin Biochem Nutr. 2011;50(2):169-175.
60. Takada K, Matsumoto S, Kojima E, et al. Prospective evaluation of the relationship between acute exacerbations of COPD and gastroesophageal reflux disease diagnosed by questionnaire. Respir Med. 2011;105:1531-1536.
61. Phulpoto M, Ozyyum S, Rizvi N, Khuhaware S. Proportion of gastroesophageal symptoms in patients with chronic obstructive pulmonary disease. J Pak Med Assoc. 2005;55:276-279.
62. Kamble N, Khan N, Kumar N, Nayak H, Daga M. Study of gastro-oesophageal reflux disease in patients with mild-to-moderate chronic obstructive pulmonary disease in India. Respirology. 2013;18:463-467.
63. Andersen L, Jensen G. Prevalence of benign oesophageal disease in the Danish population with special reference to pulmonary disease. J Intern Med. 1989;225:393-401.
64. Gadel AA, Mostafa M, Younis A, Haleem M. Esophageal motility pattern and gastroesophageal reflux in chronic obstructive pulmonary disease. Hepatogastroenterology. 2012;59(120):2498-2502.
65. Weusten B, Akkermans L, vanBerge-Henegouwen GP, Smout AJ. Spatiotemporal characteristics of physiological gastroesophageal reflux. Am J Physiol. 1994;266:G357-G362.
66. DeMeester T, Johnson L, Joseph G, Toscano M, Hall A, Skinner D. Patterns of gastroesophageal reflux in health and disease. Ann Surg. 1976;184(4):459-470.
67. Dent J, El-Serag H, Wallander M, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005;54: 710-717.
68. Areias V, Carreira S, Anciaes M, Pinto P, Barbara C. Co-morbidities in patients with gold stage 4 chronic obstructive pulmonary disease. Rev Port Pneumol. 2014;20(1):5-11.
69. McColl E. Best practice in symptom assessment: a review. Gut. 2004;53(suppl 4):49-54.
70. El-Serag H, Sonnenberg A. Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States Military Veterans. Gastroenterology. 1997;113:755-760.
71. Garcia Rodriguez L, Ruigomez A, Martin-merino E, Johansson S, Wallander M. Relationship between gastroesophageal reflux disease and COPD in UK primary care. Chest. 2008;134(6):1223-1230.
72. Pandolfino JE, Kahrilas PJ. Smoking and gastro-esophageal reflux disease. Eur J Gastroenterol Hepatol. 2000;12:837-842.
73. Kadakia SC, Kikendall JW, Maydonovitch C, Johnson LF. Effect of cigarette smoking on gastroesophageal reflux measured by 24-h ambulatory esophageal pH monitoring. Am J Gastroenterol. 1995;90:1785-1790.
74. Kim S, Lee J, Sim Y, Ryu Y, Chang J. Prevalence and risk factors for reflux esophagitis in patients with chronic obstructive pulmonary disease. Korean J Intern Med. 2014;29:466-473.
75. Hill C, Jones R. Systematic review: the epidemiology of gastro-oesophageal reflux disease in primary care, using the UK general practice research database. Aliment Pharmacol Ther. 2009;29:470-480.
76. Rahman I. Oxidative stress in pathogenesis of chronic obstructive pulmonary disease: cellular and molecular mechanisms. Cell Biochem Biophys. 2005;43:167-188.
77. Farrell S, McMaster C, Gibson D, Shields M, McCallion W. Pepsin in bronchoalveolar lavage fluid: a specific and sensitive method of diagnosing gastro-oesophageal reflux-related pulmonary aspiration. J Pediatr Surg. 2006;41:289-293.
78. Pauwels A, Decraene A, Blondeau K, et al. Bile acids in sputum and increased airway inflammation in patients with cystic fibrosis. Chest. 2012;141(6):1568-1574.
79. Eryuksel E, Dogan M, Olgun S, Kocak I, Celikel T. Incidence and treatment results of laryngopharyngeal reflux in chronic obstructive pulmonary disease. Eur Arch Otorhinolaryngol. 2009;266(8):1267-1271.
80. Lee A, Button B, Denehy L, et al. Exhaled breath condensate pepsin: potential noninvasive test for gastroesophageal reflux in COPD and bronchiectasis. Respir Care. 2015;60(2):244-250.
81. Orr W, Elsenbruch S, Harnish M, Johnson L. Proximal migration of esophageal acid perfusions during waking and sleep. Am J Gastroenterol. 2000;95:37-42.
82. Fortunato G, Machado M, Andrade C, Felicetti J, Camargo J, Cardoso P. Prevalence of gastroesophageal reflux in lung transplant candidates with advanced lung disease. J Bras Pneumol. 2008;34(10):772-778.
83. Terada K, Muro S, Ohara T, et al. Abnormal swallowing reflex and COPD exacerbations. Chest. 2010;137(2):326-332.
84. Teramoto S, Kume H, Ouchi Y. Altered swallowing physiology and aspiration in COPD. Chest. 2002;122(3):1104-1105.
85. Gross R, Atwood DJ, Ross S, Olszewski J, Eichhorn K. The coordination between breathing and swallowing in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;179(7):559-565.
86. Mokhlesi B, Logemann JA, Rademaker AW, Stangl CA, Corbridge TC. Oropharyngeal deglutition in stable COPD. Chest. 2002;121(2):361-369.
87. Mokhlesi B. Clinical implications of gastroesophageal reflux disease and swallowing dysfunction in COPD. Am J Respir Med. 2003;2(2):117-121.
88. Pauwels A, Blondeau K, Dupont L, Sifrim D. Mechanisms of increased gastroesophageal reflux in patients with cystic fibrosis. Am J Gastroenterol. 2012;107(9):1346-1353.
89. Turbyville J. Applying principles of physics to the airway to help explain the relationship between asthma and gastroesophageal reflux. Med Hypotheses. 2010;74:1075-1080.
90. Field S, Underwood M, Brant R, Cowie R. Prevalence of gastroesophageal reflux symptoms in asthma. Chest. 1996;109:316-322.
91. Naliboff BD, Mayer M, Fass R, et al. The effect of life stress on symptoms of heartburn. Psychosom Med. 2004;66(3):426-434.
92. Stein M, Towner T, Weber R. The effect of theophylline on the lower esophageal sphincter pressure. Ann Allergy. 1980;45:238.
93. 2 -adrenergic agonist on lower esophageal function: a dose-response study. Chest. 2001;121:1024-1027.
94. Kim J, Lee JH, Kim Y, et al. Association between chronic obstructive pulmonary disease and gastroesophageal reflux disease: a national cross-sectional cohort study. BMC Pulmon Med. 2013;13:51.
95. Ruzkowski C, Sanowski R, Austin J, Rohwedder JJ, Waring JP. The effects of inhaled albuterol and oral theophylline on gastroesophageal reflux in patients with gastroesophageal reflux disease and obstructive lung disease. Arch Intern Med. 1992;152(4):783-785.
96. Niklasson A, Strid H, Simren M, Engstrom C-P, Bjornsson E. Prevalence of gastrointestinal symptoms in patients with chronic obstructive pulmonary disease. Eur J Gastroenterol Hepatol. 2008;20(4):335-341.
97. Sontag S, O’Connell S, Khandelwal S, Miller T, Nemchausky B, Schnell T. Most asthmatics have gastroesophageal reflux with or without bronchodilator therapy. Gastroenterology. 1990;99:613-620.
98. Hubert D, Gaudric M, Guerre J, Lockhart A, Marsac J. Effect of theophylline on gastroesophageal reflux in patients with asthma. J Allergy Clin Immunol. 1988;81:1168-1174.
99. Kulig M, Nocon M, Vieth M, et al. Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study. J Clin Epidemiol. 2004;57:580-589.
100. Locke R, Talley N, Fett S, Zinsmeister A, Melton J. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med. 1999;106: 642-649.
101. Dore M, Maragkoudakis E, Fraley K, et al. Diet, lifestyle and gender in gastro-esophageal reflux disease. Dig Dis Sci. 2008;53(8):2017-2032.
102. Corley D, Kubo A. Body mass index and gastroesophageal reflux disease: a systematic review and meta-analysis. Am J Gastroenterol. 2006;108:2619-2628.
103. Demeter P, Pap A. The relationship between gastroesophageal reflux disease and obstructive sleep apnea. J Gastroenterol. 2004;39:815-820.
104. Zagari RM, Fuccio L, Wallander MA, et al. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett’s oesophagus in the general population: the Loiano-Monghidoro study. Gut. 2008;57(10):1354-1359.
105. Harding S. GERD, airway disease and the mechanisms of interaction. In: Stein M, editor. Gastroesophageal Reflux Disease and Airway Disease. New York: Marcel Dekker Inc; 1999:162-163.
106. Canning B, Mazzone S. Reflex mechanisms in gastroesophageal reflux disease and asthma. Am J Med. 2003;115:45S-48S.
107. Orr W, Shamma-Othman Z, Allen M, Robinson M. Esophageal function and gastroesophageal reflux during sleep and waking in patients with chronic obstructive pulmonary disease. Chest. 1992;101:1521-1525.
108. Guarascio A, Ray S, Finch C, Self T. The clinical and economic burden of chronic obstructive pulmonary disease in the USA. Clinicoeconom Outcomes Res. 2013;5:235-245.
109. Sakae T, Pizzichini M, Teixeira P, de Silva R, Trevisol D, Pizzichini E. Exacerbations of COPD and symptoms of gastroesophageal reflux: a systematic review and meta-analysis. J Bras Pneumol. 2013;39(3): 259-271.
110. Ozyilmaz E, Kokturk N, Teksut G, Tatlicioglu T. Unsuspected risk factors of frequent exacerbations requiring hospital admission in chronic obstructive pulmonary disease. Inter J Clin Pract. 2013; 67:691-697.
111. Lin Y, Tsai C, Chien L, Chiou H, Jeng C. Newly diagnosed gastroesophageal reflux disease increased the risk of acute exacerbations of chronic obstructive pulmonary disease during the first year following diagnosis - a nationwide population-based cohort study. Inter J Clin Pract. 2015;69(3):350-357.
112. Hurst J, Vestbo J, Anzueto A. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12): 1128-1138.
113. Ingebrigtsen T, Marott J, Vestbo J, Nordestgaard B, Hallas J, Lange P. Gastroesophageal reflux disease and exacerbations in chronic obstructive pulmonary disease. Respirology. 2015;20:101-107.
114. Pacheco-Galvan A, Hart S, Morice A. Relationship between gastrooesophageal reflux and airway diseases: the airway reflux paradigm. Arch Bronchoneumol. 2011;47:195-203.
115. Harding S. GERD, airway disease and the mechanisms of interaction. In: Stein M, editor. Gastroesophageal Reflux Disease and Airway Disease. New York: Marcel Dekker Inc; 1999:162–163.
116. Ajmera M, Raval A, Shen C, Sambamoorthi U. Explaining the increased health care expenditures associated with gastroesophageal reflux disease among elderly Medicare beneficiaries with chronic obstructive pulmonary disease: a cost-decomposition analysis. Int J Chron Obstruct Pulmon Dis. 2014;9:339-348.
117. National Institute for Health and Care Excellence. Chronic Obstructive Pulmonary Disease. Management of Chronic Obstructive Pulmonary Disease in Adults in Primary and Secondary Care; 2010. Available from: https://www.nice.org.uk/guidance/cg101/chapter/1-guidance. Accessed 24 February, 2015.
118. Sasaki T, Nakayama K, Yasuda H, et al. A randomised, single-blind study of lansoprazole for the prevention of exacerbations of chronic obstructive pulmonary disease in older patients. J Am Geriatr Soc. 2009;57(8):1453-1457.
119. Storr MA. What is nonacid reflux disease? Can J Gastroenterol. 2011;25(1):35-38.
120. Hartwig MG, Anderson DJ, Onaitis MW, et al. Fundoplication after lung transplantation prevents the allograft dysfunction associated with reflux. Ann Thorac Surg. 2011;92(2):462-468.
121. Gasper WJ, Sweet MP, Hoopes C, et al. Antireflux surgery for patients with end-stage lung disease before and after lung transplantation. Surg Endosc. 2008;22:495-500.
122. Hoppo T, Jarido V, Pennathur A, et al. Antireflux surgery preserves lung function in patients with gastroesophageal reflux disease and end-stage lung disease before and after lung transplantation. Arch Surg. 2011;146(9):1041-1047.
123. Ekstrom T, Johansson K. Effects of anti-reflux surgery on chronic cough and asthma in patients with gastro-oesophageal reflux disease. Respir Med. 2000;94(12):1166-1170.